全文获取类型
收费全文 | 5419篇 |
免费 | 338篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 108篇 |
妇产科学 | 277篇 |
基础医学 | 570篇 |
口腔科学 | 93篇 |
临床医学 | 559篇 |
内科学 | 1201篇 |
皮肤病学 | 63篇 |
神经病学 | 413篇 |
特种医学 | 190篇 |
外科学 | 682篇 |
综合类 | 102篇 |
一般理论 | 2篇 |
预防医学 | 245篇 |
眼科学 | 301篇 |
药学 | 457篇 |
中国医学 | 29篇 |
肿瘤学 | 471篇 |
出版年
2023年 | 16篇 |
2022年 | 56篇 |
2021年 | 151篇 |
2020年 | 62篇 |
2019年 | 120篇 |
2018年 | 166篇 |
2017年 | 104篇 |
2016年 | 120篇 |
2015年 | 167篇 |
2014年 | 202篇 |
2013年 | 256篇 |
2012年 | 407篇 |
2011年 | 371篇 |
2010年 | 291篇 |
2009年 | 225篇 |
2008年 | 304篇 |
2007年 | 328篇 |
2006年 | 322篇 |
2005年 | 278篇 |
2004年 | 236篇 |
2003年 | 204篇 |
2002年 | 178篇 |
2001年 | 168篇 |
2000年 | 158篇 |
1999年 | 135篇 |
1998年 | 43篇 |
1997年 | 50篇 |
1996年 | 34篇 |
1995年 | 29篇 |
1994年 | 34篇 |
1993年 | 19篇 |
1992年 | 81篇 |
1991年 | 56篇 |
1990年 | 69篇 |
1989年 | 42篇 |
1988年 | 33篇 |
1987年 | 43篇 |
1986年 | 32篇 |
1985年 | 31篇 |
1984年 | 19篇 |
1983年 | 10篇 |
1981年 | 11篇 |
1980年 | 23篇 |
1979年 | 20篇 |
1978年 | 17篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1975年 | 12篇 |
1972年 | 12篇 |
1971年 | 8篇 |
排序方式: 共有5815条查询结果,搜索用时 15 毫秒
101.
102.
103.
Context Oxidative stress plays a key role in neurodegenerative disorders, including Parkinson’s disease (PD). Rice fermented with Monascus purpureus Went (Monascaceae) NTU 568 (red mould rice) was found to contain antioxidants, including dimerumic acid (DMA) and deferricoprogen (DFC).Objective The effects of DMA and DFC on 6-hydroxydopamine (6-OHDA)-induced cytotoxicity and potential protective mechanisms in differentiated PC-12 pheochromocytoma cells were investigated.Materials and methods DMA (0–60?μM) or DFC (0–10?μM) was co-treated with 6-OHDA (200?μM, 24?h exposure) in differentiated PC-12 cells. Cell viability and intercellular reactive oxygen species (ROS) were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) and 2′,7′-dichlorofluorescein-diacetate (DCFH-DA) assays, respectively. Cell apoptosis was determined by DNA fragmentation analysis and propidium iodide staining by flow cytometry. Western blot analysis was used to measure the levels of cell protein expression.Results DMA and DFC significantly increased cell viability to 72% and 81% in 6-OHDA-induced differentiated PC-12 cell cultures, respectively. Furthermore, DMA and DFC reduced 6-OHDA-induced formation of extracellular and intercellular ROS by 25% and 20%, respectively, and decreased NADPH oxidase-2 expression in differentiated PC-12 cells. DMA and DFC inhibited 6-OHDA-induced apoptosis and decreased activation of caspase-3 via regulation of Bcl-2-associated X protein (Bax) and Bcl-2 protein expression in differentiated PC-12 cells.Conclusion DMA and DFC may protect against 6-OHDA toxicity by inhibiting ROS formation and apoptosis. These results showed that the metabolites from M. purpureus NTU 568 fermentation were potential therapeutic agents for PD induced by oxidative damage and should be encouraged for further research. 相似文献
104.
Real‐world effectiveness and safety of paritaprevir/ritonavir,ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
105.
Ping-Tao Tseng Hung-Yu Wang Yu-Shian Cheng Feng-Chih Shen Pao-Yen Lin Ching-Kuan Wu 《The Kaohsiung journal of medical sciences》2014,30(11):579-586
The prevalence rate of metabolic syndrome (MS) and coronary artery disease (CAD) has been found to be high in patients with chronic schizophrenia. Current evidence shows that CAD is underdiagnosed in this group. Our study evaluated the prevalence of MS and the risk of CAD in patients with chronic schizophrenia in a chronic care mental hospital in southern Taiwan. We included all patients with the diagnosis of schizophrenia or schizoaffective disorder. We collected all laboratory, physical examination, psychiatric interview, and chart review data. We also evaluated the risk of CAD in these patients using the Framingham point system. There was no significant age difference in the MS prevalence rate in these patients. The young patients with schizophrenia in our study tended to have a higher prevalence of MS than the general population. In addition, female patients had a higher prevalence rate of MS than males. Based on the Framingham point system, we found the 10-year risk of CAD to be higher among the patients with schizophrenia than in the general population. Our study highlights the importance of the high risk of MS in both younger and older patients with schizophrenia, without a significant relationship to the use of antipsychotics. More complete cohort studies are needed to confirm these findings. Psychiatrists may want to establish more specific and detailed clinical guidelines for patients with chronic schizophrenia with comorbid physical diseases, especially MS and CAD. 相似文献
106.
107.
Follistatin is a glycoprotein with various biologic functions that plays a role in adipocyte differentiation, muscle stimulation, anti-inflammation, and energy homeostasis. Thyroid hormones influence energy expenditure, glucose, and lipid metabolism. The association between serum follistatin level and thyroid function statuses has seldom been evaluated.The objectives of this study were to compare serum follistatin concentrations in different thyroid function statuses and to evaluate the associations between serum follistatin and free thyroxine (fT4) levels.In this study, 30 patients with hyperthyroidism (HY group) and 30 euthyroid individuals (EU group) were recruited. The patients of HY group were treated with antithyroid regimens as clinically indicated, whereas no medication was given to EU group. The demographic and anthropometric characteristics, biochemical data, serum levels of follistatin, and thyroid function of both groups at baseline and at the 6th month were compared. Data of all patients were pooled for the analysis of the associations between the levels of follistatin and fT4.At baseline, the HY group had significantly higher serum follistatin levels than the EU group (median [Q1, Q3]: 1.81 [1.33, 2.78] vs 1.13 [0.39, 1.45] ng/mL, P < 0.001). When treated with antithyroid regimens, the follistatin serum levels in HY group decreased to 1.54 [1.00, 1.88] ng/mL at the 6th month. In all patients, the serum levels of follistatin were positively associated with fT4 levels at baseline (β = 0.54, P = 0.005) and at the 6th month (β = 0.59, P < 0.001). The association between follistatin and fT4 levels remained significant in the stepwise multivariate regression analysis, both initially and at the 6th month.In comparison to the EU group, patients with hyperthyroidism had higher serum follistatin levels, which decreased after receiving antithyroid treatment. In addition, the serum follistatin concentrations were positively associated with serum fT4 levels in patients with hyperthyroidism or euthyroidism. 相似文献
108.
109.